Quidel | QDEL - Operating Profit


Quidel reported $-15.3M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Abbott USD 2.13B 281M Jun/2026
Agilent USD 444M 45M Jun/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Bruker USD 69.6M 59.4M Jun/2026
Cerus USD -1.45M 488K Dec/2024
Charles River Laboratories USD 119.89M 9K Jun/2026
Danaher USD 1.13B 217M Jun/2026
Haemonetics USD 57.46M 5.12M Jun/2026
Illumina USD 260M 21M Jun/2026
IQVIA Holdings USD 2.6B 2.03B Jun/2026
Merit Medical Systems USD 60.4M 16.25M Jun/2026
Mettler Toledo International USD 287.55M 53.61M Jun/2026
Myriad Genetics USD -3M 20.3M Dec/2025
Neogen USD 3.1M 6.4M Mar/2026
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quidel USD -15.3M 16.5M Jun/2026
Revvity USD 126.14M 43.36M Jun/2026
STAAR Surgical USD 10.1M 7.3M Jun/2026
Thermo Fisher Scientific USD 2.18B 273M Jun/2026
Waters USD -86M 234M Jun/2026